Cliff Asness’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
ACA
Cliff Asness's KPTI Position: Q3 2026 in Review
Cliff Asness opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 931,658 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #2990 among its holdings. This is a return to the name: Cliff Asness previously reported a position in KPTI as recently as Q3 2024.
Cliff Asness first reported a position in KPTI in Q4 2014 and has held it in 21 quarters since. The position peaked at $1.73M in Q2 2020. 92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- Cliff Asness held 931,658 shares of Karyopharm Therapeutics worth $1.14M as of Q3 2026.
- Karyopharm Therapeutics was a new Cliff Asness position in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #2990 holding.
- Cliff Asness first reported a position in Karyopharm Therapeutics in Q4 2014 and has held it in 21 quarters since.
- Cliff Asness's Karyopharm Therapeutics position peaked at $1.73M in Q2 2020.
- 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.